These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
64 related items for PubMed ID: 7793997
1. [Quality of life in patients with advanced gastric cancer receiving AO-90, a methionine-free intravenous amino acid solution, with 5-fluorouracil and mitomycin C]. Kurihara M, Kosaki G, Taguchi T, Akazawa S, Sasaki T, Takahashi H, Onodera T, Endo M, Nakagawara G, Sano K. Gan To Kagaku Ryoho; 1995 Jun; 22(7):911-23. PubMed ID: 7793997 [Abstract] [Full Text] [Related]
2. [A controlled study of AO-90, a methionine-free intravenous amino acid solution, in combination with 5-fluorouracil and mitomycin C in advanced gastric cancer patients (internal medicine group evaluation)]. Kitamura S, Ohtani T, Kurihara M, Kosaki G, Akazawa S, Sasaki T, Takahashi H, Nakano S, Tokunaga K. Gan To Kagaku Ryoho; 1995 May; 22(6):765-75. PubMed ID: 7755384 [Abstract] [Full Text] [Related]
8. A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer. Kim R, Murakami S, Ohi Y, Inoue H, Yoshida K, Toge T. Int J Oncol; 1999 Nov; 15(5):921-6. PubMed ID: 10536174 [Abstract] [Full Text] [Related]
9. Cisplatin, etoposide, and weekly high-dose 5-fluorouracil and leucovorin infusion (PE-HDFL)--a very effective regimen with good patients' compliance for advanced gastric cancer. Cheng AL, Yeh KH, Lin JT, Hsu C, Liu MY. Anticancer Res; 1998 Nov; 18(2B):1267-72. PubMed ID: 9615799 [Abstract] [Full Text] [Related]
10. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. Nashimoto A, Nakajima T, Furukawa H, Kitamura M, Kinoshita T, Yamamura Y, Sasako M, Kunii Y, Motohashi H, Yamamoto S, Gastric Cancer Surgical Study Group, Japan Clinical Oncology Group. J Clin Oncol; 2003 Jun 15; 21(12):2282-7. PubMed ID: 12805327 [Abstract] [Full Text] [Related]
11. [Randomized controlled trial of MMC + UFT and MMC + 5-FU therapy in advanced gastric cancer]. Sasagawa T, Ho N, Endo T, Sekine T, Sugiyama K, Tomidokoro T, Hatakeyama S, Togashi M, Onuki K, Katagiri J. Gan To Kagaku Ryoho; 1994 Jul 15; 21(8):1179-85. PubMed ID: 8031159 [Abstract] [Full Text] [Related]
12. [Methionine-deprived amino acid solution-induced biochemical modulation of 5-FU and augmentation of the antitumor activity]. Maeta M, Kaibara N, Sugihara K. Gan To Kagaku Ryoho; 1992 May 15; 19(5):618-23. PubMed ID: 1580636 [Abstract] [Full Text] [Related]
15. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer. Jung JY, Kwon JH, Kim JH, Song HH, Kim I, Lee KS, Kim HJ, Zang DY, Ahn JS, Lee JA, Park YI. Oncol Rep; 2009 Feb 15; 21(2):523-9. PubMed ID: 19148531 [Abstract] [Full Text] [Related]
19. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract. Cancer; 2002 Oct 15; 95(8):1685-95. PubMed ID: 12365016 [Abstract] [Full Text] [Related]
20. Phase II study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer. Kikuyama S, Inada T, Oyama R, Ogata Y. Anticancer Res; 2002 Oct 15; 22(6B):3633-6. PubMed ID: 12552968 [Abstract] [Full Text] [Related] Page: [Next] [New Search]